Financials
- Market Capitalization 15.66 B
- Employee 2 500
- Founded 1992
- CEO Kevin C. Gorman
- Website www.neurocrine.com
- Headquarter Delaware, United States
- FIGI BBG000GJS7C1
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
30.37
市销率
5.08
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 477 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 18.03 USD | -0.06% | -0.99% | +1.75% | +27.11% | 28.09 B USD | ||
| 617 | VTRS Viatris Inc. - Common Stock | 16.35 USD | -3.20% | +0.18% | -8.96% | +57.97% | 18.78 B USD | ||
| 822 | ELAN Elanco Animal Health Incorporated Common Stock | 24.12 USD | -1.59% | -0.74% | -6.18% | +7.70% | 12.05 B USD | ||
| 910 | RDY Dr. Reddy's Laboratories Ltd | 12.18 USD | +0.25% | -0.49% | +3.48% | -13.86% | 10.17 B USD |